Published in Curr Allergy Asthma Rep on December 01, 2011
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. BMC Pulm Med (2016) 1.39
Real-world research and its importance in respiratory medicine. Breathe (Sheff) (2015) 1.01
Stratified approaches to the treatment of asthma. Br J Clin Pharmacol (2013) 0.98
The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease. Respir Res (2015) 0.90
The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma. BMC Pulm Med (2015) 0.88
Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study. Respir Res (2013) 0.78
Inhaled corticosteroids used for the control of asthma in a "real-life" setting do not affect linear growth velocity in prepubertal children. Med Sci Monit (2012) 0.78
Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data study. BMC Pulm Med (2015) 0.76
Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler. ERJ Open Res (2016) 0.76
Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β₂ -agonists in obstructive lung diseases: a population-based, observational study. Int J Clin Pract (2014) 0.75
The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis. NPJ Prim Care Respir Med (2016) 0.75
Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A "Real-Life" Study. J Osteoporos (2015) 0.75
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
A comparison of observational studies and randomized, controlled trials. N Engl J Med (2000) 14.11
Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis (1967) 13.52
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess (1999) 7.00
Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med (2011) 6.89
Validity of the general practice research database. Pharmacotherapy (2003) 6.78
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med (2008) 6.17
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med (2000) 5.06
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med (1999) 4.45
Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA (2001) 4.28
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol (2004) 4.17
Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med (2003) 3.58
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med (2000) 3.25
Pragmatic trials--guides to better patient care? N Engl J Med (2011) 3.11
The Brussels Declaration: the need for change in asthma management. Eur Respir J (2008) 2.91
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med (2007) 2.78
How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med (2005) 2.62
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev (2006) 2.30
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J (2002) 2.26
Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA (2006) 2.22
Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax (2002) 2.08
A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. PLoS Med (2009) 1.99
Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med (2003) 1.99
Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med (2000) 1.80
Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy (2003) 1.80
Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol (2001) 1.78
High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. J Allergy Clin Immunol (2008) 1.76
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol (2010) 1.75
External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax (2006) 1.72
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet (2004) 1.71
The true cost of pharmacological disease prevention. BMJ (2011) 1.61
Achieving asthma control in practice: understanding the reasons for poor control. Respir Med (2008) 1.61
Clinical trials and tribulations: the MASCOT study. Thorax (2011) 1.59
Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma. Mayo Clin Proc (2002) 1.56
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med (2010) 1.55
Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med (2005) 1.54
The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J (2009) 1.51
Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest (2000) 1.48
Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma? Chest (2005) 1.44
Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma (1999) 1.38
Treatment patterns in the months prior to and after asthma-related emergency department visit. Chest (2004) 1.33
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Are overweight asthmatics more difficult to control? Allergy (2006) 1.22
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy (2008) 1.20
Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices. Clin Exp Allergy (2009) 1.18
Beclomethasone for asthma in children: effects on linear growth. Cochrane Database Syst Rev (2000) 1.10
Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax (2008) 1.04
Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network. Soc Psychiatry Psychiatr Epidemiol (2005) 1.03
Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial. J Allergy Clin Immunol (2001) 1.01
Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest (1997) 1.01
Spirometric criteria for asthma: adding further evidence to the debate. J Allergy Clin Immunol (2005) 0.98
Breaking new ground: challenging existing asthma guidelines. BMC Pulm Med (2006) 0.98
How representative are clinical study patients with allergic rhinitis in primary care? J Allergy Clin Immunol (2011) 0.98
A call for action: Comparative effectiveness research in asthma. J Allergy Clin Immunol (2010) 0.97
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. J Allergy Clin Immunol (2000) 0.96
Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Ann Allergy Asthma Immunol (2010) 0.94
Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study. Clin Exp Allergy (2011) 0.93
Against pragmatism: on efficacy, effectiveness and the real world. Trials (2009) 0.93
Database studies in asthma pharmacoeconomics: uses, limitations and quality markers. Expert Opin Pharmacother (2003) 0.91
Does smoking affect the outcome of patient education and self-management in asthmatics? Patient Educ Couns (2003) 0.90
How do observational studies expand the evidence base for therapy? JAMA (2001) 0.90
Limitations of "pragmatic" trials. Postgrad Med J (2005) 0.88
Impact of comorbidities on asthma. Expert Rev Clin Immunol (2008) 0.82
Budesonide/formoterol maintenance and reliever therapy versus conventional best practice. Respir Med (2009) 0.82
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD. J Asthma Allergy (2011) 0.82
Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol (2009) 0.81
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study. Clinicoecon Outcomes Res (2010) 0.79
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med (2011) 6.89
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol (2010) 5.80
The Norway spruce genome sequence and conifer genome evolution. Nature (2013) 4.74
Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med (2008) 3.90
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med (2005) 3.48
Scanning the genome for gene single nucleotide polymorphisms involved in adaptive population differentiation in white spruce. Mol Ecol (2008) 2.91
Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ (2002) 2.81
Influence of ICU case-volume on the management and hospital outcomes of acute exacerbations of chronic obstructive pulmonary disease*. Crit Care Med (2013) 2.75
Should we change antibiotic prophylaxis for lung surgery? Postoperative pneumonia is the critical issue. Ann Thorac Surg (2008) 2.71
Rhinitis and onset of asthma: a longitudinal population-based study. Lancet (2008) 2.68
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis. J Thorac Cardiovasc Surg (2012) 2.57
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56
Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol (2010) 2.19
Symptom-based questionnaire for identifying COPD in smokers. Respiration (2005) 2.18
Assembling the 20 Gb white spruce (Picea glauca) genome from whole-genome shotgun sequencing data. Bioinformatics (2013) 2.18
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol (2005) 2.11
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med (2006) 2.08
Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest (2008) 1.89
The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J (2011) 1.81
The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010. Prim Care Respir J (2010) 1.76
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol (2010) 1.75
Phenotypic determinants of uncontrolled asthma. J Allergy Clin Immunol (2009) 1.73
Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med (2004) 1.69
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J (2009) 1.64
Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med (2008) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Achieving asthma control in practice: understanding the reasons for poor control. Respir Med (2008) 1.61
Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently. J Mol Med (Berl) (2001) 1.60
Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. J Allergy Clin Immunol (2004) 1.59
Pneumothorax recurrence after surgery in women: clinicopathologic characteristics and management. Ann Thorac Surg (2011) 1.58
Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda. Prim Care Respir J (2013) 1.57
Enhancing genetic mapping of complex genomes through the design of highly-multiplexed SNP arrays: application to the large and unsequenced genomes of white spruce and black spruce. BMC Genomics (2008) 1.57
Generation, annotation, analysis and database integration of 16,500 white spruce EST clusters. BMC Genomics (2005) 1.54
Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study. Prim Care Respir J (2013) 1.54
A white spruce gene catalog for conifer genome analyses. Plant Physiol (2011) 1.54
Predictors of an appropriate admission to an ICU after a major pulmonary resection. Respiration (2005) 1.53
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol (2007) 1.53
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J (2013) 1.51
Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med (2007) 1.51
Prescribing of asthma medication in primary care for children aged under 10. Prim Care Respir J (2010) 1.50
Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol (2004) 1.47
Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis (2012) 1.47
Efficacy versus effectiveness trials: informing guidelines for asthma management. Curr Opin Allergy Clin Immunol (2013) 1.45
Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J (2011) 1.45
Primum non nocere. Prim Care Respir J (2005) 1.44
Symptom-based questionnaire for differentiating COPD and asthma. Respiration (2005) 1.43
Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control. Prim Care Respir J (2012) 1.43
Early postoperative prophylactic noninvasive ventilation after major lung resection in COPD patients: a randomized controlled trial. Intensive Care Med (2013) 1.42
Automated SNP detection from a large collection of white spruce expressed sequences: contributing factors and approaches for the categorization of SNPs. BMC Genomics (2006) 1.41
Clinical and biological heterogeneity in children with moderate asthma. Am J Respir Crit Care Med (2003) 1.39
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol (2013) 1.33
Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc (2014) 1.32
Association genetics of wood physical traits in the conifer white spruce and relationships with gene expression. Genetics (2011) 1.30
Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol (2012) 1.29
Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol (2012) 1.28
Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med (2011) 1.28
Scanning the genome for gene SNPs related to climate adaptation and estimating selection at the molecular level in boreal black spruce. Mol Ecol (2011) 1.28
State of world allergy report 2008: allergy and chronic respiratory diseases. World Allergy Organ J (2008) 1.27
Prognosis of cocaine body-packers. Intensive Care Med (2005) 1.27
Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol (2010) 1.27
Cognitive performance in patients with COPD. Respir Med (2004) 1.26
A spruce gene map infers ancient plant genome reshuffling and subsequent slow evolution in the gymnosperm lineage leading to extant conifers. BMC Biol (2012) 1.26
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol (2006) 1.26
Variation in mitochondrial DNA reveals multiple distant glacial refugia in black spruce (Picea mariana), a transcontinental North American conifer. Mol Ecol (2004) 1.25
Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med (2006) 1.23
Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med (2003) 1.23
Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol (2005) 1.23
Decoupled mitochondrial and chloroplast DNA population structure reveals Holocene collapse and population isolation in a threatened Mexican-endemic conifer. Mol Ecol (2006) 1.20
Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med (2010) 1.20
QTL mapping in white spruce: gene maps and genomic regions underlying adaptive traits across pedigrees, years and environments. BMC Genomics (2011) 1.20
Improving physical activity in COPD: towards a new paradigm. Respir Res (2013) 1.20
Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008. World Allergy Organ J (2012) 1.19
Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med (2002) 1.16
Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol (2009) 1.16
Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am (2004) 1.13
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol (2012) 1.13
A composite linkage map from two crosses for the species complex Picea mariana x Picea rubens and analysis of synteny with other Pinaceae. Theor Appl Genet (2005) 1.13
A mitochondrial DNA minisatellite reveals the postglacial history of jack pine (Pinus banksiana), a broad-range North American conifer. Mol Ecol (2005) 1.12
Large-scale statistical analysis of secondary xylem ESTs in pine. Plant Mol Biol (2005) 1.12
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update. Respir Med (2009) 1.11
Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med (2011) 1.10
Ten-year follow-up of cluster-based asthma phenotypes in adults. A pooled analysis of three cohorts. Am J Respir Crit Care Med (2013) 1.10
Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes (2010) 1.10
Atmospheric pressure influences the risk of pneumothorax: beware of the storm! Chest (2007) 1.10
Impact of comorbidities on COPD-specific health-related quality of life. Respir Med (2012) 1.09
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 1.08
Development of high-density SNP genotyping arrays for white spruce (Picea glauca) and transferability to subtropical and nordic congeners. Mol Ecol Resour (2013) 1.08